1229649-30-2

Upstream product

• 41762-76-9 3-chlorocarbonyl-1-methanesulfonyl-2-imidazolidinone 
• 605-62-9 4-nitro-1-naphthol 
• 1220627-07-5 2-amino-4-((4-aminonaphthalen-1-yloxy)methyl)pyridine 
• 1220627-06-4 2-amino-4-((4-nitronaphthalen-1-yloxy)methyl)pyridine 
• 105250-17-7 2-amino-4-hydroxymethylpyridine 
• 1220627-08-6 1-(4-((2-aminopyridin-4-yl)methoxy)naphthalen-1-yl)-3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)urea 

Relevant academic research and scientific papers

Inhibitors of Hemopoietic Cell Kinase (P59-HCK) and Their Use in the Treatment of Influenza Infection

The present invention relates inter alia to the treatment or prevention of influenza virus infection (including subtypes influenza A virus, influenza B virus, avian strain H5N1, A/H1N1, H3N2 and/or pandemic influenza) using compounds which inhibit the act

INHIBITORS OF HEMOPOIETIC CELL KINASE (P59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION

The present invention relates inter alia to the treatment or prevention of influenza virus infection (including subtypes influenza A virus, influenza B virus, avian strain H5N1, A/H1N1, H3N2 and/or pandemic influenza) using compounds which inhibit the activity of p59-HCK and to a method of screening for a candidate drug substance intended to prevent or treat influenza virus infection in a subject, said method comprising identifying a test substance capable of inhibiting p59-HCK activity.